Valuation: JBCHEMICAPAR

Market Cap 387B 4.06B 3.53B 3.28B 3.01B 5.69B 5.78B 38.7B 15.19B 193B 15.24B 14.9B 647B P/E 2027 *
43.3x
P/E 2028 * 33x
Enterprise Value 387B 4.06B 3.53B 3.28B 3.01B 5.69B 5.78B 38.7B 15.19B 193B 15.24B 14.9B 647B EV / Sales 2027 *
8.14x
EV / Sales 2028 * 7.12x
Free-Float
-
Yield 2027 *
0.72%
Yield 2028 * 0.86%
1 day-3.73%
Current month+5.09%
1 month+5.09%
3 months+17.78%
6 months+28.98%
Current year+32.51%
1 month 2,289.7
Extreme 2289.7
2,509.4
Current year 1,777.05
Extreme 1777.05
2,509.4
1 year 1,603.05
Extreme 1603.05
2,509.4
3 years 1,232.42
Extreme 1232.425
2,509.4
5 years 669.52
Extreme 669.525
2,509.4
10 years 118
Extreme 118
2,509.4
Date Insider Type Main position Quantity % Market Cap.
22/9/25 Sell

Chief Executive Officer

24,785 0.0159%
22/9/25 Sell

Chief Executive Officer

19,312 0.0124%
15/9/25 Sell

Chief Executive Officer

965 0.0006%

Financials

2027 *2028 *
Net sales 47.6B 499M 434M 403M 370M 700M 710M 4.76B 1.87B 23.7B 1.87B 1.83B 79.47B 54.41B 570M 495M 461M 423M 800M 812M 5.44B 2.13B 27.09B 2.14B 2.09B 90.83B
Net income 9B 94.25M 81.93M 76.26M 70.02M 132M 134M 899M 353M 4.48B 354M 346M 15.02B 11.85B 124M 108M 100M 92.25M 174M 177M 1.18B 465M 5.9B 466M 456M 19.79B
Net Debt - -
Logo JBCHEMICAPAR
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.
Employees
5,602
Sector
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,412.25INR
Average target price
2,307.12INR
Spread / Average Target
-4.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. JBCHEPHARM Stock